4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 112 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $327,721 | -47.6% | 25,744 | -25.6% | 0.00% | -100.0% |
| Q2 2023 | $625,529 | +170.2% | 34,617 | +157.1% | 0.00% | – |
| Q1 2023 | $231,464 | +1052009.1% | 13,465 | +1346400.0% | 0.00% | – |
| Q4 2022 | $22 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q3 2022 | $141,000 | +15.6% | 17,548 | +0.8% | 0.00% | – |
| Q2 2022 | $122,000 | -56.7% | 17,408 | -6.7% | 0.00% | – |
| Q1 2022 | $282,000 | -14.3% | 18,650 | +24.6% | 0.00% | – |
| Q4 2021 | $329,000 | +36.5% | 14,968 | +67.3% | 0.00% | – |
| Q3 2021 | $241,000 | – | 8,945 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 377,777 | $15,659,000 | 5.43% |
| BVF INC/IL | 1,106,070 | $45,847,000 | 1.80% |
| Eagle Health Investments LP | 50,000 | $2,073,000 | 1.33% |
| Ally Bridge Group (NY) LLC | 150,000 | $6,218,000 | 1.07% |
| Casdin Capital, LLC | 780,555 | $32,354,000 | 0.96% |
| VIKING GLOBAL INVESTORS LP | 3,937,914 | $163,227,000 | 0.45% |
| Pinz Capital Management, LP | 19,900 | $825,000 | 0.38% |
| ArrowMark Colorado Holdings LLC | 1,063,744 | $44,092,000 | 0.34% |
| Perceptive Advisors | 600,256 | $24,881,000 | 0.27% |
| ACUTA CAPITAL PARTNERS, LLC | 20,000 | $829,000 | 0.23% |